Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Convulsive Generalized Seizure Disorder

2-amino-5-phosphonovalerate has been researched along with Convulsive Generalized Seizure Disorder in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowery, NG1
Bagetta, G1
Nisticó, G1
Britton, P1
Whitton, P1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Convulsive Generalized Seizure Disorder

ArticleYear
Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: antagonism by NMDA receptor blockers.
    Epilepsy research. Supplement, 1992, Volume: 9

    Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Carbamazepine; Diazepam; Dizocilpine Maleate;

1992